A VBG is adequate for the diagnosis and ongoing management of patients with DKA. ABGs offer no added benefit and are associated with increased pain and complications.
Patients with DKA may present with a weak or absent nitroprusside assay reaction on urinalysis for ketones as this test only checks for acetoacetate (the minor ketone body produced in DKA). Serum beta-hydroxybutyrate testing may be helpful in certain cases in making the diagnosis.
There is no established role for administration of sodium bicarbonate to patients with DKA regardless of their pH. Sodium bicarbonate administration is associated with more complications including hypokalaemia and cerebral oedema.
Insulin should not be started in patients with DKA until the serum potassium level is confirmed to be > 3.5 mEq/L. The use of an insulin bolus prior to infusion has not been shown to improve any patient centred outcomes or surrogate markers and is associated with an increased rate of hypoglycaemic episodes.
Guidelines recommend checking an ABG or VBG in all patients with DKA. This practice is not evidence-based and should be abandoned.
ABG or VBG provides little information about whether or not the patient has DKA (beyond what is already known from the serum chemistries).
Rather than pH, serum bicarbonate may be used to gauge the severity of acidosis.
There is no evidence that detecting or reacting to a very low pH is helpful.
Decisions about the level of ventilatory support that a patient needs can almost always be made on a clinical basis. When in doubt, close attention to the patient with serial examination is often a sound approach. Focus on the patient, not the blood gas.
VBG might be helpful in cases where it is unclear whether the patient requires intubation, or if there is a significant underlying respiratory disease (e.g. COPD or obesity hypoventilation syndrome).
Myth #1: We should get ABGs instead of VBGs in DKA…Busted: VBG can be used in place of ABGs
Myth #2: After Intravenous Fluids (IVF), Insulin is the Next Step…Busted: After starting IVF, the next step in DKA management is electrolyte replacement, NOT Insulin.
Myth #3: Once pH <7.1, Patients Need Bicarbonate Therapy…Busted: Intravenous bicarbonate therapy may transiently make acidemia better, but there is no improvement of glycemic control, time on insulin, time to hospital discharge, and in kids can worsen cerebral oedema.
Myth #4: We Should Bolus Insulin Before Starting the Infusion…Busted: Insulin boluses increase hypoglycemic events without other clinical benefits in the treatment of DKA.
Unless you want to know a patient’s oxygenation (because your pulse oximeter has failed), stop turning your patient into a pin cushion looking for the radial artery and get a venous blood gas
Myths in DKA Management: The urban legends end here
VBG as good as ABG for diagnosis and treatment
Aggressively replete potassium prior to starting insulin
Bicarbonate is unnecessary in DKA treatment and potentially harmful
A bolus of insulin is unnecessary in DKA treatment and potentially harmful
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions. To learn more, please read our privacy policy.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
